Alan Huang
2020
In 2020, Alan Huang earned a total compensation of $589.5K as Chief Scientific Officer at Tango Therapeutics.
Compensation breakdown
| Non-Equity Incentive Plan | $135,769 |
|---|---|
| Option Awards | $70,566 |
| Salary | $373,806 |
| Other | $9,376 |
| Total | $589,517 |
Huang received $373.8K in salary, accounting for 63% of the total pay in 2020.
Huang also received $135.8K in non-equity incentive plan, $70.6K in option awards and $9.4K in other compensation.
Rankings
In 2020, Alan Huang's compensation ranked 10,559th out of 13,090 executives tracked by ExecPay. In other words, Huang earned more than 19.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 10,559 out of 13,090 | 19th |
Division Manufacturing | 4,531 out of 5,624 | 19th |
Major group Chemicals And Allied Products | 1,883 out of 2,257 | 17th |
Industry group Drugs | 1,649 out of 1,957 | 16th |
Industry Pharmaceutical Preparations | 1,217 out of 1,462 | 17th |
Source: SEC filing on April 26, 2022.
Huang's colleagues
We found two more compensation records of executives who worked with Alan Huang at Tango Therapeutics in 2020.